Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine

被引:18
|
作者
Wu, Fan [1 ]
Yuan, Xiao-Yi [1 ]
Huang, Wei-Shan [1 ]
Chen, Ying-Hua [1 ]
机构
[1] Tsinghua Univ, Immunol Lab, Dept Biol, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
关键词
Influenza virus; Combined vaccination; M2e; Split influenza vaccine; Heterosubtypic protection; PANDEMIC CONTROL STRATEGIES; EXTRACELLULAR DOMAIN; AVIAN INFLUENZA; A H5N1; VIRUS; IMMUNITY; PROTEIN; MICE; INFECTION;
D O I
10.1016/j.vaccine.2008.11.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is urgent need to develop influenza vaccines with broad-spectrum protection against the potential influenza pandemic. The extracellular domain of influenza M2 protein (M2e) is considered as an appropriate target to induce heterosubtypic protection. We investigated the immunity and protection induced by combined vaccination with synthetic M2e peptide and traditional split influenza vaccine. The combined vaccination was able to induce similar strain-specific hemagglutinin inhibition (HI) antibodies as vaccination of split virus alone. However, aluminum-adjuvant but not oil-in-water-emulsion adjuvant combined vaccination was able to induce high titers of anti-M2e antibodies and provoke M2e-specific T lymphocyte response. Furthermore, we found that the addition of M2e peptide greatly enhanced the cross-protective efficacy of split virus in aluminum adjuvant but slightly weakened the efficacy of vaccination in oil-in-water-emulsion adjuvant. Moreover, aluminum-adjuvant combined vaccination conferred complete cross-protection against heterosubtypic influenza virus. According to the results, we suggest that the M2e peptide should be added into split influenza vaccine in the preparation for the potential influenza pandemic. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6095 / 6101
页数:7
相关论文
共 50 条
  • [1] Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine
    Carignan, Damien
    Therien, Ariane
    Rioux, Gervais
    Paquet, Genevieve
    Gagne, Marie-Eve Laliberte
    Bolduc, Marilene
    Savard, Pierre
    Leclerc, Denis
    VACCINE, 2015, 33 (51) : 7245 - 7253
  • [2] Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine
    Adler-Moore, Jill
    Munoz, Meilen
    Kim, Hana
    Romero, Juan
    Tumpey, Terrence
    Zeng, Hui
    Petro, Chris
    Ernst, William
    Kosina, Suzie
    Jimenez, Gretchen
    Fujii, Gary
    VACCINE, 2011, 29 (27) : 4460 - 4468
  • [3] A single-shot vaccine approach for the universal influenza A vaccine candidate M2e
    Kavishna, Ranmali
    Kang, Tha Yang
    Vacca, Maurizio
    Chua, Benson Yen Leong
    Park, Hae-Young
    Tan, Peck Szee
    Chow, Vincent Tk
    Lahoud, Mireille H.
    Alonso, Sylvie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (13)
  • [4] An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
    Ma, Ji-Hong
    Yang, Fu-Ru
    Yu, Hai
    Zhou, Yan-Jun
    Li, Guo-Xin
    Huang, Meng
    Wen, Feng
    Tong, Guangzhi
    VIROLOGY JOURNAL, 2013, 10
  • [5] The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine
    Wu, Fan
    Yuan, Xiao-Yi
    Li, Jing
    Chen, Ying-Hua
    VACCINE, 2009, 27 (32) : 4320 - 4324
  • [6] M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection
    Tao, Wenqian
    Gill, Harvinder S.
    VACCINE, 2015, 33 (20) : 2307 - 2315
  • [7] Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge
    Layton, S. L.
    Kapczynski, D. R.
    Higgins, S.
    Higgins, J.
    Wolfenden, A. D.
    Liljebjelke, K. A.
    Bottje, W. G.
    Swayne, D.
    Berghman, L. R.
    Kwon, Y. M.
    Hargis, B. M.
    Cole, K.
    POULTRY SCIENCE, 2009, 88 (11) : 2244 - 2252
  • [8] Vaccination with Different M2e Epitope Densities Confers Partial Protection against H5N1 Influenza A Virus Challenge in Chickens
    Zhang, Xintao
    Liu, Ming
    Liu, Chunguo
    Du, Jinling
    Shi, Weilin
    Sun, Encheng
    Li, Hongtao
    Li, Jianhui
    Zhang, Yun
    INTERVIROLOGY, 2011, 54 (05) : 290 - 299
  • [9] Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA)
    Mu, Xupeng
    Hu, Kebang
    Shen, Mohan
    Kong, Ning
    Fu, Changhao
    Yan, Weiqun
    Wei, Anhui
    JOURNAL OF VIROLOGICAL METHODS, 2016, 228 : 84 - 90
  • [10] Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin
    Liu, Xiaoyu
    Guo, Jianqiang
    Han, Su
    Yao, Lihong
    Chen, Aijun
    Yang, Qi
    Bo, Hong
    Xu, Pengwei
    Yin, Jiyong
    Zhang, Zhiqing
    VACCINE, 2012, 30 (46) : 6527 - 6533